Publisert: 12. september 2019

Here are the four talks from the seminar on Direct-to-consumer genetic testing in Oslo that took place on August 9th.

The seminar was a collaboration between The Nordic Committee on Bioethics and The Norwegian Biotechnology Advisory Board and part of the the 33rd European conference on philosophy of medicine and health care: PHILOSOPHY AND ETHICS AT THE EDGE OF MEDICINE. 

Time: August 9th 2019, 10.30-12.55
Place: University of Oslo library, House of Georg Sverdrup
Organizers: The Nordic Committee on Bioethics and  The Norwegian Biotechnology Advisory Board



  • Emilie Niemiec, Centre for Research Ethics & Bioethics, Uppsala University, Sweden.

New offers of direct-to-consumer genetic testing and new ethical problems

  • Henry Alexander Henrysson, Dep. of philosophy, University of Iceland / The National Bioethics Committee.

DTC GT in a Small and Homogenous Population: The Future of Health Care or a Pandora Box of Insurmountable Societal Challenges?

  • Santa Slokenberga, medical law, University of Lund / Centre for Research Ethics & Bioethics Uppsala, Sweden.

Ascertaining child’s ‘best interests’ through direct-to-consumer genetic testing: what could possibly be wrong with that?

  • Anne-Marie Axø Gerdes, Professor, Dep. of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital and The University of Copenhagen, Denmark. Chair of The Danish Council of Ethics.

The Danish Council on Ethics recommendations about Genome Testing with focus on Direct to consumer genetic testing.


Chairs: Madeleine Hayenhjelm (NCBIO) and Truls Petersen (NCBIO/The Norw. Biotechn. Adv. Board)



logo bioteknologirådet